Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...
If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...
Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
Beyond the Gates has an extremely emotionally week ahead on March 23 to 27, 2026 with Anita’s health set to decline ...
Avalyn, a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced the initiation of the AURA ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds ...
The study is a promising breakthrough that could eventually prove key to understanding the disease’s mysterious origins, its ...
Nearly half a million Louisianans have lost coverage through Medicaid since 2023, causing challenges for patients and ...
There are no known procedures to neutralize the effects of jet fuel exposure, and there's no clinical guidance for long-term ...
Diclofenac gel and the topical flavonoid silymarin, or milk thistle, may be effective in preventing chemotherapy-induced hand ...
Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications. But experts say the drugs alone aren't ...
Engaging in a simple home-based exercise regimen of walking and resistance training during chemotherapy can help patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results